Retour
Fourchette du Jour
334,17 €
335,87 €
Fourchette 52 Semaines
221,26 €
362,41 €
Volume
516 371
Moyenne 50J / 200J
341,27 €
/
283,75 €
Clôture Précédente
335,56 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (627 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 73,8 | 0,3 |
| P/B | 9,2 | 2,9 |
| ROE % | 13,8 | 3,7 |
| Net Margin % | 12,7 | 3,8 |
| Rev Growth 5Y % | 17,1 | 10,0 |
| D/E | 0,2 | 0,2 |
Objectif de Cours des Analystes
Hold
371,92 €
+11.3%
Low: 349,00 €
High: 388,00 €
P/E Prévisionnel
66,8
BPA Prévisionnel
5,02 €
Croissance BPA (est.)
+0,0%
CA Est.
1,6 B
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2029 |
9,25 €
8,93 € – 9,57 €
|
2,3 B | 2 |
| FY2028 |
7,60 €
7,03 € – 8,91 €
|
2 B | 4 |
| FY2027 |
6,37 €
5,47 € – 6,90 €
|
1,8 B | 11 |
Points Clés
Revenue grew 17,06% annually over 5 years — strong growth
Earnings grew 1168,11% over the past year
ROE of 13,78% — decent returns on equity
Debt/Equity of 0,15 — conservative balance sheet
Generating 174,93M in free cash flow
P/E of 73,80 — premium valuation
Croissance
Revenue Growth (5Y)
17,06%
Revenue (1Y)17,50%
Earnings (1Y)1168,11%
FCF Growth (3Y)45,95%
Qualité
Return on Equity
13,78%
ROIC8,62%
Net Margin12,66%
Op. Margin13,48%
Sécurité
Debt / Equity
0,15
Current Ratio6,64
Interest Coverage0,00
Valorisation
P/E Ratio
73,80
P/B Ratio9,19
EV/EBITDA69,47
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 17,50% | Revenue Growth (3Y) | 15,15% |
| Earnings Growth (1Y) | 1168,11% | Earnings Growth (3Y) | 39,77% |
| Revenue Growth (5Y) | 17,06% | Earnings Growth (5Y) | 140,81% |
| Profitability | |||
| Revenue (TTM) | 1,40B | Net Income (TTM) | 177,69M |
| ROE | 13,78% | ROA | 9,73% |
| Gross Margin | 67,14% | Operating Margin | 13,48% |
| Net Margin | 12,66% | Free Cash Flow (TTM) | 174,93M |
| ROIC | 8,62% | FCF Growth (3Y) | 45,95% |
| Safety | |||
| Debt / Equity | 0,15 | Current Ratio | 6,64 |
| Interest Coverage | 0,00 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | 73,80 | P/B Ratio | 9,19 |
| P/S Ratio | 9,34 | PEG Ratio | 0,06 |
| EV/EBITDA | 69,47 | Dividend Yield | 0,00% |
| Market Cap | 13,11B | Enterprise Value | 13,15B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1,40B | 1,19B | 1,06B | 847,13M | 747,59M |
| Net Income | 177,69M | 14,01M | 90,95M | -2,00M | 5,28M |
| EPS (Diluted) | 4,52 | 0,36 | 2,32 | -0,05 | 0,14 |
| Gross Profit | 942,44M | 755,00M | 682,64M | 535,21M | 475,38M |
| Operating Income | 189,25M | 9,28M | 73,55M | 6,08M | -7,50M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1,83B | 1,53B | 1,56B | 1,37B | 1,24B |
| Total Liabilities | 398,92M | 382,25M | 377,36M | 372,03M | 290,32M |
| Shareholders' Equity | 1,43B | 1,15B | 1,18B | 998,86M | 953,93M |
| Total Debt | 219,70M | 223,39M | 234,34M | 235,77M | 173,55M |
| Cash & Equivalents | 186,90M | 324,40M | 167,49M | 69,86M | 59,38M |
| Current Assets | 1,22B | 951,13M | 915,40M | 755,70M | 681,47M |
| Current Liabilities | 183,13M | 158,35M | 151,14M | 144,93M | 123,20M |